242 related articles for article (PubMed ID: 26679830)
1. Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial.
Day CA; Shanahan M; Wand H; Topp L; Haber PS; Rodgers C; Deacon R; Walsh N; Kaldor J; van Beek I; Maher L;
J Clin Virol; 2016 Jan; 74():66-72. PubMed ID: 26679830
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia.
Topp L; Day CA; Wand H; Deacon RM; van Beek I; Haber PS; Shanahan M; Rodgers C; Maher L;
Prev Med; 2013 Oct; 57(4):297-303. PubMed ID: 23639625
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A
Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721
[TBL] [Abstract][Full Text] [Related]
4. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
Wong J; Payne M; Hollenberg S
J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
[TBL] [Abstract][Full Text] [Related]
5. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial.
Weaver T; Metrebian N; Hellier J; Pilling S; Charles V; Little N; Poovendran D; Mitcheson L; Ryan F; Bowden-Jones O; Dunn J; Glasper A; Finch E; Strang J
Lancet; 2014 Jul; 384(9938):153-63. PubMed ID: 24725468
[TBL] [Abstract][Full Text] [Related]
6. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
[TBL] [Abstract][Full Text] [Related]
7. Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia.
Deacon RM; Topp L; Wand H; Day CA; Rodgers C; Haber PS; van Beek I; Maher L
J Urban Health; 2012 Oct; 89(5):769-78. PubMed ID: 22684422
[TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence.
Rafia R; Dodd PJ; Brennan A; Meier PS; Hope VD; Ncube F; Byford S; Tie H; Metrebian N; Hellier J; Weaver T; Strang J
Addiction; 2016 Sep; 111(9):1616-27. PubMed ID: 26990598
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
[TBL] [Abstract][Full Text] [Related]
11. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
[TBL] [Abstract][Full Text] [Related]
12. A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.
Haussig JM; Nielsen S; Gassowski M; Bremer V; Marcus U; Wenz B; Bannert N; Bock CT; Zimmermann R;
Int J Infect Dis; 2018 Jan; 66():5-13. PubMed ID: 29097248
[TBL] [Abstract][Full Text] [Related]
13. Short-term immunogenicity of standard and accelerated hepatitis B virus vaccination schedules in healthy adults: a comparative field study in China.
Zhang X; Wang J; Chen X; Yu M; Yu S; Sun Y; Duan J; Sun H; Yuan P
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30201691
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection.
Collier MG; Drobeniuc J; Cuevas-Mota J; Garfein RS; Kamili S; Teshale EH
Vaccine; 2015 Jun; 33(24):2808-12. PubMed ID: 25889161
[TBL] [Abstract][Full Text] [Related]
15. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
[TBL] [Abstract][Full Text] [Related]
19. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
20. Outcome of a hepatitis B vaccination program for clients of a drug consumption facility.
Scherbaum N; Timm J; Richter F; Bonnet U; Bombeck J; Lajos S; Specka M
J Clin Virol; 2018 Sep; 106():28-32. PubMed ID: 30015286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
